Glucocorticoids, 11β-hydroxysteroid dehydrogenase, and fetal programming

Kidney International

Volumn 57, Issue 4, 2000, Pages 1412-1417

  Seckl, Jonathan R ^a   Cleasby, Mark ^a   Nyirenda, Moffat J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Fetal growth; Glucocorticoid receptor; Hypertension; Placenta; Type 2 diabetes mellitus

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CARBENOXOLONE; DEXAMETHASONE; GLUCOCORTICOID; HYDROCORTISONE; HYDROXYSTEROID DEHYDROGENASE;

CARDIOVASCULAR DISEASE; CONFERENCE PAPER; ENZYME ACTIVITY; FETUS DEVELOPMENT; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRAUTERINE GROWTH RETARDATION; LOW BIRTH WEIGHT; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRENATAL EXPOSURE; PRIORITY JOURNAL; ANIMAL; ENZYMOLOGY; FEMALE; FETUS; PHYSIOLOGY; PLACENTA; PREGNANCY; REVIEW;

11-BETA-HYDROXYSTEROID DEHYDROGENASES; ANIMALS; FEMALE; FETUS; GLUCOCORTICOIDS; HUMANS; HYDROXYSTEROID DEHYDROGENASES; PLACENTA; PREGNANCY;

EID: 0033624814     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00984.x     Document Type: Conference Paper

References (74)

1. 1. BARKER DJP, WINTER PD, OSMOND C, MARGETTS B, SIMMONDS SJ: Weight in infancy and death from ischaemic heart disease. Lancet 2:577-580, 1989
2. 2. BARKER DJP: Fetal and Infant Origins of Adult Disease, London, British Medical Journal Publishing, 1991, pp 1-343
3. 3. BARKER DJP, GLUCKMAN PD, GODFREY KM, HARDING JE, OWENS JA, ROBINSON JS: Fetal nutrition and cardiovascular disease in adult life. Lancet 341:938-941, 1993
4. 4. BARKER DJP: The fetal origins of hypertension. J Hypertens 14(Suppl):S117-S120, 1996
5. 5. CURHAN GC, CHERTOW GM, WILLETT WC, SPIEGELMAN D, COLDITZ GA, MANSON JE, SPEIZER FE, STAMPFER MJ: Birth-weight and adult hypertension and obesity in women. Circulation 94:1310-1315, 1996
6. 6. CURHAN GC, WILLETT WC, RIMM EB, SPIEGELMAN D, ASCHERIO AL, STAMPFER MJ: Birth weight and adult hypertension, diabetes mellitus, and obesity in US men. Circulation 94:3246-3250, 1996
7. 7. FALL CHD, OSMOND C, BARKER DJP, CLARK PMS, HALES CN, STIRLING Y, MEADE TW: Fetal and infant growth and cardiovascular risk factors in women. Br Med J 310:428-432, 1995
8. 8. RICHEDWARDS JW, STAMPFER MJ, MANSON JE, ROSNER B, HANKINSON SE, COLDITZ GA, WILLETT WC, HENNEKENS CH: Birth weight and risk of cardiovascular disease in a cohort of women followed up since 1976. Br Med J 315:396-400, 1997
9. 9. LEON DA, KOUPILOVA I, LITHELL HO, BERGLUND L, MOHSEN R, VAGERO D, LITHELL UB, MCKEIGUE PM: Failure to realise growth potential in utero and adult obesity in relation to blood pressure in 50 year old Swedish men. Br Med J 312:401-406, 1996
10. 10. LITHELL HO, MCKEIGUE PM, BERGLUND L, MOHSEN R, LITHELL UB, LEON DA: Relation of size at birth to non-insulin dependent diabetes and insulin concentrations in men aged 50-60 years. Br Med J 312:406-410, 1996
11. 11. MOORE VM, MILLER AG, BOULTON TJC, COCKINGTON RA, CRAIG IH, MAGAREY AM, ROBINSON JS: Placental weight, birth measurements, and blood pressure at age 8 years. Arch Dis Child 74:538-541, 1996
12. 12. FORSEN T, ERIKSSON JG, TUOMILEHTO J, TERAMO K, OSMOND C, BARKER DJP: Mother's weight in pregnancy and coronary heart disease in a cohort of Finnish men: Follow up study. Br Med J 315:837-840, 1997
13. 13. YAJNIK CS, FALL CHD, VAIDYA U, PANDIT AN, BAVDEKAR A, BHAT DS, OSMOND C, HALES CN, BARKER DJP: Fetal growth and glucose and insulin metabolism in four-year-old Indian children. Diabet Med 12:330-336, 1995
14. 14. LEVINE RS, HENNEKENS CH, JESSE MJ: Blood pressure in prospective population based cohort of newborn and infant twins. Br Med J 308:298-302, 1994
15. 15. OSMOND C, BARKER DJP, WINTER PD, FALL CHD, SIMMONDS SJ: Early growth and death from cardiovascular disease in women. Br Med J 307:1524-1527, 1993
16. 16. BARKER DJP, BULL AR, OSMOND C, SIMMONDS SJ: Fetal and placental size and risk of hypertension in adult life. Br Med J 301:259-263, 1990
17. 17. EDWARDS CRW, BENEDIKTSSON R, LINDSAY R, SECKL JR: Dysfunction of the placental glucocorticoid barrier: A link between the foetal environment and adult hypertension? Lancet 341:355-357, 1993
18. 18. SECKL JR: Physiologic programming of the fetus. Clin Perinatol 25:939-964, 1998
19. 19. HATTERSLEY A, BEARDS F, BALLANTYNE E, APPLETON M, HARVEY R, ELLARD S: Mutations in the glucokinase gene of the fetus result in reduced birth weight. Nat Genet 19:268-270, 1998
20. 20. DUNGER D, ONG K, HUXTABLE S, SHERRIFF A, WOODS K, AHMED M, GOLDING J, PEMBREY M, RING S, BENNETT S, TODD J: Association of the INS VNTR with size at birth. Nat Genet 19:98-100, 1998
21. 21. LANGLEY SC, JACKSON AA: Increased systolic blood pressure in adult rats induced by fetal exposure to maternal low protein diets. Clin Sci 86:217-222, 1994
22. 22. LANGLEY-EVANS SC, PHILLIPS GJ, JACKSON AA: In utero exposure to maternal low protein diets induces hypertension in weanling rats independently of maternal blood pressure changes. Clin Nutr 13:319-324, 1994
23. 23. PETRY CJ, OZANNE SE, WANG CL, HALES CN: Early protein restriction and obesity independently induce hypertension in 1-year-old rats. Clin Sci 93:147-152, 1997
24. 24. WOODALL SM, JOHNSTON BM, BRFIER BH, GLUCKMAN PD: Chronic maternal undernutrition in the rat leads to delayed postnatal growth and elevated blood pressure of offspring. Pediatr Res 40:438-443, 1996
25. 25. MATHEWS F, YUDKIN P, NEIL A: Influence of maternal nutrition on outcome of pregnancy: Prospective cohort study. Br Med J 319:339-343, 1999
26. 26. STANNER SA, BULMER K, ANDRES C, LANTSEVA OE, BORODINA V, POTEEN VV, YUDKIN JS: Does malnutrition in utero determine diabetes and coronary heart disease in adulthood? Results from the Leningrad siege study, a cross sectional study. Br Med J 315:1342-1348, 1997
27. 27. ARAI Y, GORSKI RA: Critical exposure time for androgenization of the developing hypothalamus in the female rat. Endocrinology 82:1010-1014, 1968
28. 28. GUSTAFSSON JA, STENBERG A: Neonatal programming of androgen responsiveness of liver of adult rats. J Biol Chem 249:719-723, 1974
29. 29. REINISCH JM, SIMON NG, KARWO WG, GANDELMAN R: Prenatal exposure to prednisone in humans and animals retards intra-uterine growth. Science 202:436-438, 1978
30. 30. NOVY MJ, WALSH SW: Dexamethasone and estradiol treatment in pregnant rhesus macaques: Effects on gestation length, maternal plasma hormones and fetal growth. Am J Obstet Gynecol 145:920-930, 1983
31. 31. MOSIER HD JR, DEARDEN LC, JANSONS RA, ROBERTS RC, BIGGS CS: Disproportionate growth of organs and body weight following glucocorticoid treatment of the rat fetus. Dev Pharmacol Ther 4:89-105, 1982
32. 32. BERRY LM, POLK DH, IKEGAMI M, JOBE AH, PADBURY JF, ERVIN MG: Preterm newborn lamb renal and cardiovascular responses after fetal or maternal antenatal betamethasone. Am J Physiol 41:R1972-R1979, 1997
33. 33. GOLAND RS, JOZAK S, WARREN WB, CONWELL IM, STARK RI, TROPPER PJ: Elevated levels of umbilical cord plasma corticotropin-releasing hormone in growth-retarded fetuses. J Clin Endocrinol Metab 77:1174-1179, 1993
34. 34. GOLAND RS, TROPPER PJ, WARREN WB, STARK RI, JOZAK SM, CONWELL IM: Concentrations of corticotropin-releasing hormone in the umbilical-cord blood of pregnancies complicated by preeclampsia. Reprod Fertil Dev 7:1227-1230, 1995
35. 35. MEANEY MJ, AITKEN DH, VIAU V, SHARMA S, SARRIEAU A: Neonatal handling alters adrenocortical negative feedback sensitivity and hippocampal type II glucocorticoid receptor binding in the rat. Neuroendocrinology 50:597-604, 1989
36. 36. HENRY C, KABBAJ M, SIMON H, LE MOAL M, MACCARI S: Prenatal stress increases the hypothalamo-pituitary-adrenal axis response in young and adult rats. J Neuroendocrinol 6:341-345, 1994
37. 37. LEVINE S: Infantile experience and resistance to physiological stress. Science 126:405-406, 1957
38. 38. CATALANI A, MARINELLI M, SCACCIANOCE S, NICOLAI R, MUSCOLO LAA, PORCU A, KORANYI L, PIAZZA PV, ANGELUCCI L: Progeny of mothers drinking corticosterone during lactation has lower stress-induced corticosterone secretion and better cognitive performance. Brain Res 624:209-215, 1993
39. 39. DIAZ R, FUXE K, OGREN SO: Prenatal corticosterone treatment induces long-term changes in spontaneous and apomorphine-mediated motor activity in male and female rats. Neuroscience 81:129-140, 1997
40. 40. WEINSTOCK M, MATLINA E, MAOR GI, ROSEN H, MCEWEN BS: Prenatal stress selectively alters the reactivity of the hypothalamic-pituitary adrenal system in the female rat. Brain Res 595:195-200, 1992
41. 41. REDEI E, HALASZ I, LI LF, PRYSTOWSKY MB, AIRD F: Maternal adrenalectomy alters the immune and endocrine functions of fetal alcohol-exposed male offspring. Endocrinology 133:452-460, 1993
42. 42. Deleted in proof
43. 43. CELSI G, KISTNER A, AIZMAN R, EKLOF AC, CECCATELLI S, DESANTIAGO A, JACOBSON SH: Prenatal dexamethasone causes oligonephronia, sodium retention, and higher blood pressure in the offspring. Pediatr Res 44:317-322, 1998
44. 44. DIAZ R, BROWN RW, SECKL JR: Ontogeny of mRNAs encoding glucocorticoid and mineralocorticoid receptors and 11β-hydroxysteroid dehydrogenases in prenatal rat brain development reveal complex control of glucocorticoid action. J Neurosci 18:2570-2580, 1998
45. 45. COLE TJ, BLENDY JA, MONAGHAN AP, SCHMID W, AGUZZI A, SCHUTZ G: Molecular genetic analysis of glucocorticoid signaling during mouse development. Steroids 60:93-96, 1995
46. 46. TONOLO G, FRASER R, CONNELL JMC, KENYON CJ: Chronic low-dose infusions of dexamethasone in rats: Effect on blood pressure, body weight and plasma atrial natriuretic peptide. J Hypertens 6:25-31, 1988
47. 47. TANGALAKIS K, LUMBERS ER, MORITZ KM, TOWSTOLESS MK, WINTOUR EM: Effect of cortisol on blood pressure and vascular reactivity in the ovine fetus. Exp Physiol 77:709-717, 1992
48. 48. KARI MA, HALLMAN M, ERONEN M, TERAMO K, VIRTANEN M, KOIVISTO M, IKONEN RS: Prenatal dexamethasone treatment in conjunction with rescue therapy of human surfactant: A randomized placebo-controlled multicenter study. Pediatrics 93:730-736, 1994
49. 49. BENEDIKTSSON R, LINDSAY R, NOBLE J, SECKL JR, EDWARDS CRW: Glucocorticoid exposure in utero: A new model for adult hypertension. Lancet 341:339-341, 1993
50. 50. LEVITT N, LINDSAY RS, HOLMES MC, SECKL JR: Dexamethasone in the last week of pregnancy attenuates hippocampal glucocorticoid receptor gene expression and elevates blood pressure in the adult offspring in the rat. Neuroendocrinology 64:412-418, 1996
51. 51. NYIRENDA MJ, LINDSAY RS, KENYON CJ, BURCHELL A, SECKL JR: Glucocorticoid exposure in late gestation permanently programmes rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring. J Clin Invest 101:2174-2181, 1998
52. 52. BEITENS IZ, BAYARD F, ANCES IG, KOWARSKI A, MIGEON CJ: The metabolic clearance rate, blood production, interconversion and transplacental passage of cortisol and cortisone in pregnancy near term. Pediatr Res 7:509-519, 1973
53. 53. CAMPBELL AL, MURPHY BEP: The maternal-fetal cortisol gradient during pregnancy and at delivery. J Clin Endocrinol Metab 45:435-440, 1977
54. 54. MURPHY BEP, CLARK SJ, DONALD IR, PINSKY M, VEDADY DL: Conversion of maternal cortisol to cortisone during placental transfer to the human fetus. Am J Obstet Gynecol 118:538-541, 1974
55. 55. LOPEZ-BERNAL A, FLINT APF, ANDERSON ABM, TURNBULL AC: 11β-Hydroxysteroid dehydrogenase activity (E.C.1.1.1.146) in human placenta and decidua. J Steroid Biochem 13:1081-1087, 1980
56. 56. BENEDIKTSSON R, CALDER AA, EDWARDS CRW, SECKL JR: Placental 11β-hydroxysteroid dehydrogenase type 2 is the placental barrier to maternal glucocorticoids: Ex vivo studies. Clin Endocrinol 46:161-166, 1997
57. 57. STEWART PM, ROGERSON FM, MASON JI: Type 2, 11β-hydroxysteroid dehydrogenase messenger RNA and activity in human placenta and fetal membranes: its relationship to birth weight and putative role in fetal steroidogenesis. J Clin Endocrinol Metab 80:885-890, 1995
58. 58. ROGERSON FM, KAYES KM, WHITE PC: Variation in placental type 2, 11beta-hydroxysteroid dehydrogenase activity is not related to birth weight or placental weight. Mol Cell Endocrinol 128:103-109, 1997
59. 59. DAVE-SHARMA S, WILSON RC, HARBISON MD, NEWFIELD R, AZAR M, KROZOWSKI ZS, FUNDER JW, SHACKLETON CHL, BRADLOW HL, WEI JO, HERTECANT J, MORAN A, NEIBERGER RE, BALFE JW, FATTAH A, DANEMAN D, AKKURT HI, DESANTIS C, NEW MI: Extensive personal experience: Examination of genotype and phenotype relationships in 14 patients with apparent mineralocorticoid excess. J Clin Endocrinol Metab 83:2244-2254, 1998
60. 60. BENEDIKTSSON R, BRENNAND J, TIBI L, CALDER AA, SECKL JR, EDWARDS CRW: Fetal osteocalcin levels are related to placental 11β-hydroxysteroid dehydrogenase activity. Clin Endocrinol 42:551-555, 1995
61. 61. LINDSAY RS, LINDSAY RM, EDWARDS CRW, SECKL JR: Inhibition of 11β-hydroxysteroid dehydrogenase in pregnant rats and the programming of blood pressure in the offspring. Hypertension 27:1200-1204, 1996
62. 62. LINDSAY RS, LINDSAY RM, WADDELL B, SECKL JR: Programming of glucose tolerance in the rat: Role of placental 11β-hydroxysteroid dehydrogenase. Diabetologia 39:1299-1305, 1996
63. 63. LANGLEY-EVANS SC, PHILIPS G, BENEDIKTSSON R, GARDNER D, EDWARDS CRW, JACKSON AA, SECKL JR: Maternal dietary protein restriction, placental glucocorticoid metabolism and the programming of hypertension. Placenta 17:169-172, 1996
64. 64. LANGLEY-EVANS SC: Hypertension induced by foetal exposure to a maternal low-protein diet, in the rat, is prevented by pharmacological blockade of maternal glucocorticoid synthesis. J Hypertens 15:537-544, 1997
65. 65. KOTELEVTSEV Y, BROWN RW, FLEMING S, KENYON CJ, EDWARDS CRW, SECKL JR, MULLINS JJ: Hypertension in mice lacking 11β-hydroxysteroid dehydrogenase type 2. J Clin Invest 103:683-689, 1999
66. 66. BROWN RW, DIAZ R, ROBSON AC, KOTELEVTSEV Y, MULLINS JJ, KAUFMAN MH, SECKL JR: The ontogeny of 11β-hydroxysteroid dehydrogenase type 2 and mineralocorticoid receptor gene expression reveal intricate control of glucocorticoid action in development. Endocrinology 137:794-797, 1996
67. 67. PEPE GJ, BABISCHKIN JS, BURCH MG, LEAVITT MG, ALBRECHT ED: Developmental increase in expression of the messenger ribonucleic acid and protein levels of 11beta-hydroxysteroid dehydrogenase types 1 and 2 in the baboon placenta. Endocrinology 137:5678-5684, 1996
68. 68. HIMMELMANN A, SVENSSON A, HANSSON L: 5 Year follow up of blood pressure and left ventricular mass in children with different maternal histories of hypertension: The hypertension in pregnancy offspring study. J Hypertens 12:89-95, 1994
69. 69. HIMMELMANN A, HIMMELMANN K, SVENSSON A, HANSSON L: Glucose and insulin levels in young subjects with different maternal histories of hypertension: The hypertension in pregnancy offspring study. J Intern Med 241:19-22, 1997
70. 70. STEWART PM, MURRY BA, MASON JI: Type 2, 11β-hydroxysteroid dehydrogenase in human fetal tissues. J Clin Endocrinol Metab 78:1529-1532, 1994
71. 71. RINGLER GE, KALLEN CB, STRAUSS JFI: Regulation of human trophoblast function by glucocorticoids: Dexamethasone promotes increased secretion of chorionic gonadotropin. Endocrinology 124:1625-1631, 1989
72. 72. STEELE PA, FLINT APF, TURNBULL AC: Activity of steroid C-17,20-lyase in the ovine placenta: Effect of exposure to foetal glucocorticoid. J Endocrinol 69:239-246, 1976
73. 73. KARALIS K, GOODWIN G, MAJZOUB JA: Cortisol blockade of progesterone: A possible molecular mechanism involved in the initiation of human labor. Nat Med 2:556-560, 1996
74. 74. PHILLIPS DI, FALL CHD, WHORWOOD CB, SECKL JR, WOOD PJ, BARKER DJP, WALKER BR: Elevated plasma cortisol concentrations: An explanation for the relationship between low birth weight and adult cardiovascular risk factors. J Clin Endocrinol Metab 83:757-760, 1998